In The News
True You in The News
True You Weight Loss is a leading national authority on medically supervised weight loss and the treatment of obesity. Our triple board-certified physicians are pioneers in the latest research and treatment advances and are called upon frequently by the leading news organizations to offer our expertise, knowledge, perspective, and opinion. Our unique endoscopic procedures and research are routinely featured in the most trusted medical journals and national media outlets.
Active Research Projects
Ablate Weight Study
True You is excited to have launched a new Gastric Fundus Ablation plus Endoscopic Sleeve Gastroplasty for Weight Loss (ABLATE WEIGHT) study developed and led by our True You Research Team, for those interested in ESG and contributing to evidence-based research. This study aims to evaluate a new technique to reduce hunger when combined with ESG.
Class III Obesity & ESG: Weight, Health Benefits
The aim of this project was to determine if ESG is a safe and effective option for patients with a BMI of 40+ who are not interested in, or eligible for, traditional bariatric therapy through a retrospective, international, multicenter chart review. This retrospective study evaluated the data of over 400 patients who underwent ESG by one of two experienced bariatric endoscopists (Dr. Christopher McGowan of True You Weight Loss and Dr. Anna Hoff of Angioskope in Sao Paulo, Brazil) between May of 2018 and March of 2022 with class III obesity (BMI 40+).
PERCEBT: Unveiling Endoscopy Patient Profiles
Endoscopic bariatric therapies (EBTs), including the endoscopic sleeve gastroplasty (ESG) and intragastric balloons (IGBs), represent lower-risk yet effective weight loss options for patients not interested in, or eligible for, traditional bariatric surgery. However, there is limited scientific literature addressing the factors associated with receptivity to EBTs in eligible patients.
